How genetic risk contributes to autoimmune liver disease

Area of Science:

• Genetics
• Immunology
• Hepatology

Background:

• Genome-wide association studies (GWAS) have identified over 100 susceptibility loci for autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).
• Identifying causative variants and understanding their functional impact on liver cells and the immune microenvironment remains challenging.
• Current polygenic risk scores (PRS) have limited predictive power for individual disease risk.

Purpose of the Study:

• To explore advanced genetic and transcriptomic approaches for a deeper understanding of autoimmune liver diseases (AILDs).
• To delineate the shared genetic components across AIH, PBC, and PSC.
• To bridge the gap between genetic discoveries and their functional implications in liver immunology.

Main Methods:

• Leveraging genome-wide association meta-analyses (GWMA) data.
• Applying statistical fine-mapping and chromosome X-wide association testing.
• Utilizing single-cell RNA sequencing (scRNA-seq) to analyze liver-resident immune cells and cell subpopulations.

Main Results:

• Evidence suggests that genetic risk variants mediate a substantial portion of gene expression at susceptibility loci in AILDs.
• scRNA-seq in PBC and PSC shows promise for understanding genetic variant impact on specific liver cell types.
• Comparative genomic and transcriptomic analyses between AIH, PBC, and PSC are proposed to clarify shared genetic underpinnings.

Conclusions:

• Advanced genetic and transcriptomic analyses, including scRNA-seq, offer new avenues for understanding the genetic architecture of AILDs.
• Future research should focus on integrating multi-omics data to elucidate the functional roles of identified risk variants.
• These approaches hold promise for uncovering the complex interplay between genetics and the immune system in the pathogenesis of AIH, PBC, and PSC.